Cormorant Global Healthcare Master Fund, LP

Other

Cormorant Global Healthcare Master Fund, LP (Other) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Corbus Pharmaceuticals Holdings, Inc. (CRBP). The largest single filing was $46.8M of MLTX (6,494,151 sh across 4 lots, as filed), executed Sep 29 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$46.8M

shares × price, as filed

Last traded

Sep 29 2025

Filed Oct 1 2025

Median ADV $5.2M across their filed names

Open performance→

Volume by month

Buys $3.0M Sells $46.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

CRBP

Corbus Pharmaceuticals Holdings, Inc. CRBP · 1 buy · 0 sells 1 filing DRUG DRUG DRUG · 1 buy · 0 sells 1 filing MLTX

MoonLake Immunotherapeutics MLTX · 0 buys · 1 sell 1 filing

Recent filings

MLTXSALE MoonLake Immunotherapeutics View filing → $46.8M
6,494,151 sh across 4 lots
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET DRUGPURCHASE BRIGHT MINDS BIOSCIENCES INC. View filing → $3.0M
400,675 sh across 6 lots
Exec Oct 15 2024
Filed Oct 17 2024 · 5:30 PM ET CRBPPURCHASE Corbus Pharmaceuticals Holdings, Inc. View filing → $7.0M
350,000 sh across 6 lots
Exec Sep 20 2024
Filed Sep 24 2024 · 5:30 PM ET